Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors

Published:2024-12 Issue: Volume:23 Page:2964-2977
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Odugbemi Adeshina I.,Nyirenda Clement,Christoffels Alan,Egieyeh Samuel A.

Funder

National Research Foundation

Publisher

Elsevier BV

Reference161 articles.

1. Estimated research and development investment needed to bring a new medicine to market, 2009-2018;Wouters;JAMA,2020

2. Estimating the cost of industry investment in drug research and development: a review of methods and results;Rennane;Inquiry,2022

3. Artificial intelligence in drug discovery and development;Paul;Drug Discov Today,2021

4. AI in drug discovery and its clinical relevance;Qureshi;Heliyon,2023

5. AI-based modeling: techniques, applications and research issues towards automation, intelligent and smart systems;Sarker;SN Comput Sci,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP